We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SNSE market cap is 15.22M. The company's latest EPS is USD -1.3602 and P/E is -0.45.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.01M | -10.18M | -7.74M | -8.14M | -8.73M |
| Net Income | -10.18M | -9.39M | -7.12M | -7.41M | -7.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.44M | -19.45M | -37.48M | -50.19M | -37.06M |
| Net Income | -20.54M | -20.2M | -36.79M | -48.59M | -34.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 107.93M | 89.58M | 81.66M | 74.37M | 66.7M |
| Total Liabilities | 13.08M | 10.38M | 10.66M | 9.48M | 8.22M |
| Total Equity | 94.85M | 79.2M | 71M | 64.9M | 58.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.22M | 21.43M | 153.23M | 118.38M | 74.37M |
| Total Liabilities | 22.33M | 5.54M | 6.71M | 14.97M | 9.48M |
| Total Equity | -68.66M | -56.44M | 146.51M | 103.41M | 64.9M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.74M | -21.2M | -25.86M | -32.02M | -7.62M |
| Investing | 2.31M | 21.84M | 30.15M | 38.41M | 5.77M |
| Financing | -262k | -8.21M | -10.74M | -11.17M | -209k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.57M | -17.71M | -30.26M | -39.03M | -32.02M |
| Investing | -53k | -1.4M | -143.12M | 49.95M | 38.41M |
| Financing | 8.22M | 35.45M | 163.94M | -287k | -11.17M |
| Market Cap | 15.22M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.18 |
| Price to Book Ratio | 0.24 |
| Dividend Yield | - |
| Shares Outstanding | 25.07M |
| Average Volume (1 week) | 73.72k |
| Average Volume (1 Month) | 287.65k |
| 52 Week Change | -54.36% |
| 52 Week High | 1.94 |
| 52 Week Low | 0.51 |
| Spread (Intraday) | 0.18 (23.08%) |
| Company Name | Sensei Biotherapeutics Inc |
| Address |
800 north state street dover, delaware 19901 |
| Website | https://www.senseibio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
